Skip to content

Comparative Effects of Hypopressive and Transverses Abdominis Focused Core Training in Postpartum

Comparative Effects of Hypopressive and Transverses Abdominis Focused Core Training on Urinary Incontinence, Pelvic Floor Function and Quality of Life in Postpartum

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07576283
Enrollment
60
Registered
2026-05-08
Start date
2025-10-01
Completion date
2026-08-01
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum

Keywords

urinary incontinence, pelvic floor function, quality of life, postpartum, female

Brief summary

The study aims to compare the effectiveness of these two core training approaches in improving urinary incontinence, pelvic floor function, and quality of life in postpartum women.

Detailed description

The primary outcomes of this study are urinary incontinence, pelvic floor function, and quality of life in postpartum women. These outcomes will be assessed using validated instruments: the International Consultation on Incontinence Questionnaire-Urinary Incontinence (ICIQ-UI) for evaluating the severity of urinary incontinence, the King's Health Questionnaire (KHQ) for assessing the impact on pelvic floor function and health-related quality of life, and the Incontinence Impact Questionnaire (IIQ-7) for measuring the broader impact of incontinence on daily activities and emotional well-being. Outcome measures will be measured at baseline and after 4 weeks. Data analysis will be done by SPSS version 25.

Interventions

OTHERhypopressive training

Frequency: 3 sessions/week under supervision Duration: 30-40 minutes/session For 6 weeks

OTHERtransverses abdominis focused core training

3 sessions/week under supervision Duration: 30-40 minutes/session For 6 weeks

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Multiparous women with urinary incontinence * Who had undergone normal vaginal delivery * Free from any medical and gynecological risk factors and /or conditions * Stress urinary incontinence test is positive: Pad test

Exclusion criteria

* Had neurological impairments or connective tissue disorders * Active urinary or vaginal infection in the past 3 months * Had known detrusor instability * Had undergone previous surgery to alleviate SUI * Had pelvic organ prolapse

Design outcomes

Primary

MeasureTime frameDescription
International Consultation on Incontinence Questionnaire - Urinary Incontinence6th weekThe tool is used for assessing urinary incontinence symptoms by measuring the frequency, severity, and impact of urinary leakage on quality of life. It includes specific questions related to how often leakage occurs, the amount of urine lost, and how these symptoms affect various aspects of daily life, providing a comprehensive evaluation of the individual's condition
King's Health Questionnaire6th weekThe tool is used for evaluating the impact of urinary incontinence on the quality of life in women, offering a comprehensive understanding of how stress urinary incontinence (SUI) affects their physical, emotional, and social well-being. It is particularly relevant for postpartum women, as it captures the functional limitations and lifestyle disruptions caused by incontinence, making it a valuable instrument for assessing the broader effects of SUI on daily life.
Incontinence Impact Questionnaire6th weekThe Incontinence Impact Questionnaire (IIQ) is a validated self-report tool designed to measure the impact of urinary incontinence on a woman's quality of life across physical, social, and emotional domains.30 items divided into four domains: Physical activity (6 items), Travel (6 items), Social relationships (10 items), Emotional health (8 items)

Countries

Pakistan

Contacts

CONTACTimran amjad
imran.amjad@riphah.edu.pk03324390125
PRINCIPAL_INVESTIGATORhina gul, PhD*

Riphah International University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026